TIMESPAN & ART-CARMA
- KCL (30 Nov 2023) ART-CARMA – The ADHD Remote Technology study of cardiometabolic risk factors and medication adherence
- HTN – Health Tech Newspaper (12 Apr 2021) Wearable tech and smartphone apps to be used in new ADHD project
- RADAR BASE (18 Jan 2022) TIMESPAN: ART-CARMA
- KCL (17 Jan 2022) ART-CARMA – The ADHD Remote Technology study of cardiometabolic risk factors and medication adherence
- empatica (17 Jan 2022) ART-CARMA study: measuring and improving medication adherence in adults with ADHD using EmbracePlus
TIMESPAN in the media
- ADHD Europe (no date) Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients
- EASO (no date) EU projects
- IRIS – Rannsóknir á Íslandi (no date) Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients
- Universtitätsklinkum Bonn (no date) International cooperations
- AU (5 May 2021) Major EU grant strengthens Danish ADHD research – Aarhus University newsroom
- SUNY (29 April 2021) Three Upstate researchers participate in international study looking at ADHD and cardiometabolic disease
- KI (20 April 2021) New European Commission Horizon 2020 grant – “TIMESPAN” – Karolinska Institutet Newsroom
- UOL (20 April 2021) Improving treatment for ADHD patients with cardiometabolic diseases – University of Iceland
- KCL (08 April 2021) ART-CARMA Clinical Study part of 6m Euro global programme – Mirage News
- KCL (08 April 2021) ART-CARMA Clinical Study part of 6m Euro global programme – King’s College London
- UNSW (06 April 2021) Funding drives research into treating people with ADHD and cardiometabolic diseases – UNSW Newsroom
- VHIR (01 April 2021) TIMESPAN – Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients –
TIMESPAN non-English editions
Online articles in the Estonian press
2022
- UTARTU (23 August 2022) Geenid näitavad kätte ka ajuhaiguste põhjused – Tervis.Postimees
TIMESPAN & EASO Newsletter
2022
2021